{"transactions":[{"id":1676032,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-18T21:05:23.000Z","date":"2024-01-11","kind":"grant","planned":false,"acquired":true,"shares":13011,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018, which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), was entitled to receive (the \"Earnout Rights\") up to 338,889 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\"), with such Earnout Shares to be issued upon the satisfaction of certain aggregate net revenue criteria. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC, on a pro rata basis. On January 11, 2024, in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the final Marking Period had been achieved and issued an aggregate of 19,818 shares of its common stock, including 13,011 to Coffman Family Office, LLC."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018, which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), was entitled to receive (the \"Earnout Rights\") up to 338,889 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\"), with such Earnout Shares to be issued upon the satisfaction of certain aggregate net revenue criteria. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC, on a pro rata basis. On January 11, 2024, in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the final Marking Period had been achieved and issued an aggregate of 19,818 shares of its common stock, including 13,011 to Coffman Family Office, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018, which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), was entitled to receive (the \"Earnout Rights\") up to 338,889 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\"), with such Earnout Shares to be issued upon the satisfaction of certain aggregate net revenue criteria. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC, on a pro rata basis. On January 11, 2024, in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the final Marking Period had been achieved and issued an aggregate of 19,818 shares of its common stock, including 13,011 to Coffman Family Office, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 81,867 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 305,828 shares held of record by the Coffman Family Office. The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business. Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management. The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote all the shares of common stock held by the Coffman Family Office."}],"balance_after":387695,"source":{"system":"sec-edgar","filing":"0001437749-24-001621","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774924001621/rdgdoc.xml","form_type":"4"}},{"id":2187853,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-08-12T00:37:56.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":226840,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On August 9, 2022 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the June 30, 2022 quarter of the Third Marketing Period had been achieved and the Issuer issued an aggregate of 409,505 shares of its common stock representing the June 30, 2022 Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended. Included in this issuance was the issuance of 268,840 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On August 9, 2022 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the June 30, 2022 quarter of the Third Marketing Period had been achieved and the Issuer issued an aggregate of 409,505 shares of its common stock representing the June 30, 2022 Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended. Included in this issuance was the issuance of 268,840 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 13,176,746 shares held of record by the Coffman Family Office. The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business. Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management. The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 11,471,812 shares of common stock held by the Coffman Family Office. The balance of 1,436,094 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors. The voting rights to the 1,436,094 shares vest on December 20, 2023."}],"balance_after":16860746,"source":{"system":"sec-edgar","filing":"0001654954-22-011089","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495422011089/section16.xml","form_type":"4"}},{"id":2263086,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock","published_at":"2022-05-19T20:08:04.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":301253,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On May 17, 2022 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the March 31, 2022 quarter of the Third Marketing Period had been achieved and the Issuer issued an aggregate of 458,877 shares of its common stock representing the March 31, 2022 Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 301,253 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On May 17, 2022 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the March 31, 2022 quarter of the Third Marketing Period had been achieved and the Issuer issued an aggregate of 458,877 shares of its common stock representing the March 31, 2022 Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 301,253 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 12,907,906 shares held of record by the Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business.  Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 10,035,718 shares of common stock held by the Coffman Family Office.  The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023."}],"balance_after":16591906,"source":{"system":"sec-edgar","filing":"0001654954-22-007215","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495422007215/section16.xml","form_type":"4"}},{"id":2359302,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common stock","published_at":"2022-03-02T21:06:08.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":291646,"ownership":{"direct":false,"nature":"see footnote 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On February 28, 2022 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the December 31, 2021 quarter of the Third Marketing Period had been achieved and the Issuer issued an aggregate of 444,243 shares of its common stock representing the December 31, 2021 Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 291,646 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On February 28, 2022 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the December 31, 2021 quarter of the Third Marketing Period had been achieved and the Issuer issued an aggregate of 444,243 shares of its common stock representing the December 31, 2021 Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 291,646 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 12,606,653 shares held of record by the Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business.  Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 9,734,465 shares of common stock held by the Coffman Family Office.  The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023."}],"balance_after":16290653,"source":{"system":"sec-edgar","filing":"0001654954-22-002406","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495422002406/section16.xml","form_type":"4"}},{"id":2455960,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common stock","published_at":"2021-12-30T21:06:34.000Z","date":"2021-12-28","kind":"grant","acquired":true,"shares":306397,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On December 28, 2021 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the September 30, 2021 quarter of the Third Marking Period had been achieved and the Issuer issued an aggregate of 466,713 shares of its common stock representing the September 30, 2021 quarter of the Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 306,397 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On December 28, 2021 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the September 30, 2021 quarter of the Third Marking Period had been achieved and the Issuer issued an aggregate of 466,713 shares of its common stock representing the September 30, 2021 quarter of the Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 306,397 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 12,315,007 shares held of record by the Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business.  Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 9,442,819 shares of common stock held by the Coffman Family Office.  The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023."}],"balance_after":15999007,"source":{"system":"sec-edgar","filing":"0001654954-21-013624","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421013624/section16.xml","form_type":"4"}},{"id":2595780,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common Stock","published_at":"2021-08-19T11:49:29.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":330400,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On August 16, 2021 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the June 30, 2021 quarter of the Third Marking Period had been achieved and the Issuer issued an aggregate of 503,275 shares of its common stock representing the June 30, 2021 quarter of the Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 330,400 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months (the \"Third Marking Period\"), and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the Third Marking Period to change the determination of the aggregate net revenues within the Third Marking Period to a quarterly basis for each of the six fiscal quarters within the Third Marking Period, beginning with the quarter ended March 31, 2021, instead of following the Third Marking Period end date which was 18 months after the beginning of the third marking period. On August 16, 2021 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the June 30, 2021 quarter of the Third Marking Period had been achieved and the Issuer issued an aggregate of 503,275 shares of its common stock representing the June 30, 2021 quarter of the Third Marking Period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 330,400 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 12,006,432 shares held of record by the Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business.  Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 8,765,108 shares of common stock held by the Coffman Family Office.  The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023."}],"balance_after":15690432,"source":{"system":"sec-edgar","filing":"0001654954-21-009233","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421009233/section16.xml","form_type":"4"}},{"id":2707135,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common stock","published_at":"2021-05-19T00:35:13.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":369136,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the third marking period to change the determination of the aggregate net revenues within the third marking period to a quarterly basis for each of the six fiscal quarters within the third marking period, beginning with the quarter ended March 31, 2021, instead of following third marking period end date which was 18 months after the beginning of the third marking period.  On May 14, 2021 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the March 31, 2021 quarter of the third marking period had been achieved and the Issuer issued an aggregate of 562,278 shares of its common stock representing the March 1, 2021 quarter of the third marking period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 369,136 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months, 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 31, 2021 the Issuer entered into Addendum No. 1 to the Merger Agreement with the members of CBDH which amended the measurement periods within the third marking period to change the determination of the aggregate net revenues within the third marking period to a quarterly basis for each of the six fiscal quarters within the third marking period, beginning with the quarter ended March 31, 2021, instead of following third marking period end date which was 18 months after the beginning of the third marking period.  On May 14, 2021 in accordance with the terms of the Merger Agreement, as amended, the Issuer determined that the net revenue criteria for the March 31, 2021 quarter of the third marking period had been achieved and the Issuer issued an aggregate of 562,278 shares of its common stock representing the March 1, 2021 quarter of the third marking period Earnout Shares which were earned under the terms of the Merger Agreement, as amended.  Included in this issuance was the issuance of 369,136 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 11,676,032 shares held of record by the Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business.  Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 8,803,855 shares of common stock held by the Coffman Family Office.  The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023."}],"balance_after":15360032,"source":{"system":"sec-edgar","filing":"0001654954-21-006007","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421006007/section16.xml","form_type":"4"}},{"id":2796196,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common Stock","published_at":"2021-03-11T02:01:06.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":2196126,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months (the \"Second Marking Period\"), 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 8, 2021 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the Second Marking Period had been achieved and the Issuer issued an aggregate of 3,348,250 shares of its common stock representing the Second Marking Period Earnout Shares which were earned under the terms of the Merger Agreement.  Included in this issuance was the issuance of 2,196,126 Earnout Shares to Coffman Family Office."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), CBD Holding, LLC (\"CBDH\"), then the sole member of Cure Based Development, LLC, was entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the \"Earnout Shares\") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months (the \"Second Marking Period\"), 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC (\"Coffman Family Office\"), on a pro rata basis. On March 8, 2021 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the Second Marking Period had been achieved and the Issuer issued an aggregate of 3,348,250 shares of its common stock representing the Second Marking Period Earnout Shares which were earned under the terms of the Merger Agreement.  Included in this issuance was the issuance of 2,196,126 Earnout Shares to Coffman Family Office."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,684,000 shares held of record by Edge of Business, LLC (\"Edge of Business\"); and (ii) 11,306,896 shares held of record by the Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business.  Coffman Management, LLC (\"Coffman Management\") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 8,434,708 shares of common stock held by the Coffman Family Office.  The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023."}],"balance_after":14990896,"source":{"system":"sec-edgar","filing":"0001654954-21-002571","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002571/section16.xml","form_type":"4"}},{"id":2838029,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common stock","published_at":"2021-02-24T02:00:59.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":122000,"price":4.2525,"value":518805.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001654954-21-002011","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002011/section16.xml","form_type":"4"}},{"id":2838028,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO, President, Director"}}],"security":"Common stock","published_at":"2021-02-24T02:00:59.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":3000,"price":4.2819,"value":12845.7,"ownership":{"direct":true},"balance_after":122000,"source":{"system":"sec-edgar","filing":"0001654954-21-002011","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002011/section16.xml","form_type":"4"}},{"id":3240574,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"Earnout Rights","published_at":"2020-02-28T21:30:42.000Z","date":"2020-02-26","kind":"other","acquired":true,"shares":6645230,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the terms of the Merger Agreement, CBDH was also entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock (the \"Earnout Shares\") as part of the merger consideration upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months (the \"First Marking Period\"), 24 calendar months (the \"Second Marking Period\"), 42 calendar months (the \"Third Marking Period\"), and 59 calendar months (the \"Fourth Marking Period\").  Pursuant to the terms of the CBDH Distribution Agreement, CBDH distributed the Earnout Rights to its members on a pro rata basis.  On February 27, 2020 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the First Marking Period had been achieved and an aggregate of 5,127,792 Earnout Shares were to be issued (the \"First Marking Period Earnout Shares\").  After giving effect to the First Marking Period Earnout Shares, Earnout Rights to an aggregate of 10,122,208 Earnout Shares (the \"Remaining Earnout Rights\") remain under the terms of the Merger Agreement.  Represents the pro rata number of the First Marking Period Earnout Shares issued to the Reporting Person."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents the pro rata number of Remaining Earnout Rights distributed to the Reporting Person pursuant to the terms of the CBDH Distribution Agreement."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, CBDH was also entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock (the \"Earnout Shares\") as part of the merger consideration upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months (the \"First Marking Period\"), 24 calendar months (the \"Second Marking Period\"), 42 calendar months (the \"Third Marking Period\"), and 59 calendar months (the \"Fourth Marking Period\").  Pursuant to the terms of the CBDH Distribution Agreement, CBDH distributed the Earnout Rights to its members on a pro rata basis.  On February 27, 2020 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the First Marking Period had been achieved and an aggregate of 5,127,792 Earnout Shares were to be issued (the \"First Marking Period Earnout Shares\").  After giving effect to the First Marking Period Earnout Shares, Earnout Rights to an aggregate of 10,122,208 Earnout Shares (the \"Remaining Earnout Rights\") remain under the terms of the Merger Agreement.  Represents the pro rata number of the First Marking Period Earnout Shares issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, CBDH was also entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock (the \"Earnout Shares\") as part of the merger consideration upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months (the \"First Marking Period\"), 24 calendar months (the \"Second Marking Period\"), 42 calendar months (the \"Third Marking Period\"), and 59 calendar months (the \"Fourth Marking Period\").  Pursuant to the terms of the CBDH Distribution Agreement, CBDH distributed the Earnout Rights to its members on a pro rata basis.  On February 27, 2020 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the First Marking Period had been achieved and an aggregate of 5,127,792 Earnout Shares were to be issued (the \"First Marking Period Earnout Shares\").  After giving effect to the First Marking Period Earnout Shares, Earnout Rights to an aggregate of 10,122,208 Earnout Shares (the \"Remaining Earnout Rights\") remain under the terms of the Merger Agreement.  Represents the pro rata number of the First Marking Period Earnout Shares issued to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, CBDH was also entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock (the \"Earnout Shares\") as part of the merger consideration upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months (the \"First Marking Period\"), 24 calendar months (the \"Second Marking Period\"), 42 calendar months (the \"Third Marking Period\"), and 59 calendar months (the \"Fourth Marking Period\").  Pursuant to the terms of the CBDH Distribution Agreement, CBDH distributed the Earnout Rights to its members on a pro rata basis.  On February 27, 2020 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the First Marking Period had been achieved and an aggregate of 5,127,792 Earnout Shares were to be issued (the \"First Marking Period Earnout Shares\").  After giving effect to the First Marking Period Earnout Shares, Earnout Rights to an aggregate of 10,122,208 Earnout Shares (the \"Remaining Earnout Rights\") remain under the terms of the Merger Agreement.  Represents the pro rata number of the First Marking Period Earnout Shares issued to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, CBDH was also entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock (the \"Earnout Shares\") as part of the merger consideration upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months (the \"First Marking Period\"), 24 calendar months (the \"Second Marking Period\"), 42 calendar months (the \"Third Marking Period\"), and 59 calendar months (the \"Fourth Marking Period\").  Pursuant to the terms of the CBDH Distribution Agreement, CBDH distributed the Earnout Rights to its members on a pro rata basis.  On February 27, 2020 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the First Marking Period had been achieved and an aggregate of 5,127,792 Earnout Shares were to be issued (the \"First Marking Period Earnout Shares\").  After giving effect to the First Marking Period Earnout Shares, Earnout Rights to an aggregate of 10,122,208 Earnout Shares (the \"Remaining Earnout Rights\") remain under the terms of the Merger Agreement.  Represents the pro rata number of the First Marking Period Earnout Shares issued to the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes securities held of record by Edge of Business, LLC and Coffman Family Office, LLC, entities over which the Reporting Person has voting and dispositive control.  The Reporting Person disclaims beneficial ownership of securities held of record by Edge of Business, LLC and Coffman Family Office, LLC except to the extent of his pecuniary interest therein."}],"balance_after":6645230,"derivative":{"underlying":"Common Stock","underlying_shares":6645230},"source":{"system":"sec-edgar","filing":"0001654954-20-002076","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420002076/section16.xml","form_type":"4"}},{"id":3240573,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"Common Stock","published_at":"2020-02-28T21:30:42.000Z","date":"2020-02-27","kind":"other","acquired":true,"shares":3366395,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, CBDH was also entitled to receive (the \"Earnout Rights\") up to 15,250,000 additional shares of the Issuer's common stock (the \"Earnout Shares\") as part of the merger consideration upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months (the \"First Marking Period\"), 24 calendar months (the \"Second Marking Period\"), 42 calendar months (the \"Third Marking Period\"), and 59 calendar months (the \"Fourth Marking Period\").  Pursuant to the terms of the CBDH Distribution Agreement, CBDH distributed the Earnout Rights to its members on a pro rata basis.  On February 27, 2020 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the First Marking Period had been achieved and an aggregate of 5,127,792 Earnout Shares were to be issued (the \"First Marking Period Earnout Shares\").  After giving effect to the First Marking Period Earnout Shares, Earnout Rights to an aggregate of 10,122,208 Earnout Shares (the \"Remaining Earnout Rights\") remain under the terms of the Merger Agreement.  Represents the pro rata number of the First Marking Period Earnout Shares issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Under the terms of the Merger Agreement the Second Tranche Shares were subject to a Voting Proxy Agreement pending the vesting of unrestricted voting rights, of which unrestricted voting rights to an aggregate of 2,187,500 shares vested on December 20, 2019.  Pursuant to the Voting Proxy Agreement, the voting rights to the shares of the Issuer's common stock for which unrestricted voting rights have not yet vested are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  On February 26, 2020, in connection with the CBDH Distribution Agreement, the CBDH members including the Reporting Person entered into similar Voting Proxy Agreements with the Issuer.  The Reporting Person holds unrestricted voting rights to 1,436,094 Second Tranche Shares, and the remaining 4,308,281 Second Tranche Shares distributed to the Reporting Person are subject to the Voting Proxy Agreement, with unrestricted voting rights thereto vesting in equal thirds on December 20, 2020, June 20, 2022 and December 20, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Under the terms of the Merger Agreement the Second Tranche Shares were subject to a Voting Proxy Agreement pending the vesting of unrestricted voting rights, of which unrestricted voting rights to an aggregate of 2,187,500 shares vested on December 20, 2019.  Pursuant to the Voting Proxy Agreement, the voting rights to the shares of the Issuer's common stock for which unrestricted voting rights have not yet vested are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  On February 26, 2020, in connection with the CBDH Distribution Agreement, the CBDH members including the Reporting Person entered into similar Voting Proxy Agreements with the Issuer.  The Reporting Person holds unrestricted voting rights to 1,436,094 Second Tranche Shares, and the remaining 4,308,281 Second Tranche Shares distributed to the Reporting Person are subject to the Voting Proxy Agreement, with unrestricted voting rights thereto vesting in equal thirds on December 20, 2020, June 20, 2022 and December 20, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes securities held of record by Edge of Business, LLC and Coffman Family Office, LLC, entities over which the Reporting Person has voting and dispositive control.  The Reporting Person disclaims beneficial ownership of securities held of record by Edge of Business, LLC and Coffman Family Office, LLC except to the extent of his pecuniary interest therein."}],"balance_after":12919770,"source":{"system":"sec-edgar","filing":"0001654954-20-002076","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420002076/section16.xml","form_type":"4"}},{"id":3240572,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"Common Stock","published_at":"2020-02-28T21:30:42.000Z","date":"2020-02-26","kind":"other","acquired":true,"shares":5744375,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), an aggregate of 8,750,000 shares of the Issuer's common stock (the \"Second Tranche Shares\") were issued to CBD Holding, LLC (\"CBDH\") in April 2019 as partial consideration under the terms of the Merger Agreement. The Reporting Person held dispositive control over securities held of record by CBDH.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the \"CBDH Distribution Agreement\"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis.  Represents the distribution of the Second Tranche Shares under the CBDH Distribution Agreement and the acquisition of a pro rata number of Second Tranche Shares distributed to the Reporting Person, a member of CBDH, by CBDH."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), an aggregate of 8,750,000 shares of the Issuer's common stock (the \"Second Tranche Shares\") were issued to CBD Holding, LLC (\"CBDH\") in April 2019 as partial consideration under the terms of the Merger Agreement. The Reporting Person held dispositive control over securities held of record by CBDH.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the \"CBDH Distribution Agreement\"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis.  Represents the distribution of the Second Tranche Shares under the CBDH Distribution Agreement and the acquisition of a pro rata number of Second Tranche Shares distributed to the Reporting Person, a member of CBDH, by CBDH."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Under the terms of the Merger Agreement the Second Tranche Shares were subject to a Voting Proxy Agreement pending the vesting of unrestricted voting rights, of which unrestricted voting rights to an aggregate of 2,187,500 shares vested on December 20, 2019.  Pursuant to the Voting Proxy Agreement, the voting rights to the shares of the Issuer's common stock for which unrestricted voting rights have not yet vested are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors.  On February 26, 2020, in connection with the CBDH Distribution Agreement, the CBDH members including the Reporting Person entered into similar Voting Proxy Agreements with the Issuer.  The Reporting Person holds unrestricted voting rights to 1,436,094 Second Tranche Shares, and the remaining 4,308,281 Second Tranche Shares distributed to the Reporting Person are subject to the Voting Proxy Agreement, with unrestricted voting rights thereto vesting in equal thirds on December 20, 2020, June 20, 2022 and December 20, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes securities held of record by Edge of Business, LLC and Coffman Family Office, LLC, entities over which the Reporting Person has voting and dispositive control.  The Reporting Person disclaims beneficial ownership of securities held of record by Edge of Business, LLC and Coffman Family Office, LLC except to the extent of his pecuniary interest therein."}],"balance_after":9553375,"source":{"system":"sec-edgar","filing":"0001654954-20-002076","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420002076/section16.xml","form_type":"4"}},{"id":3240571,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"Common Stock","published_at":"2020-02-28T21:30:42.000Z","date":"2020-02-26","kind":"other","acquired":false,"shares":8750000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), an aggregate of 8,750,000 shares of the Issuer's common stock (the \"Second Tranche Shares\") were issued to CBD Holding, LLC (\"CBDH\") in April 2019 as partial consideration under the terms of the Merger Agreement. The Reporting Person held dispositive control over securities held of record by CBDH.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the \"CBDH Distribution Agreement\"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis.  Represents the distribution of the Second Tranche Shares under the CBDH Distribution Agreement and the acquisition of a pro rata number of Second Tranche Shares distributed to the Reporting Person, a member of CBDH, by CBDH."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the \"Closing Date\"), an aggregate of 8,750,000 shares of the Issuer's common stock (the \"Second Tranche Shares\") were issued to CBD Holding, LLC (\"CBDH\") in April 2019 as partial consideration under the terms of the Merger Agreement. The Reporting Person held dispositive control over securities held of record by CBDH.  On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the \"CBDH Distribution Agreement\"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis.  Represents the distribution of the Second Tranche Shares under the CBDH Distribution Agreement and the acquisition of a pro rata number of Second Tranche Shares distributed to the Reporting Person, a member of CBDH, by CBDH."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes securities held of record by Edge of Business, LLC and Coffman Family Office, LLC, entities over which the Reporting Person has voting and dispositive control.  The Reporting Person disclaims beneficial ownership of securities held of record by Edge of Business, LLC and Coffman Family Office, LLC except to the extent of his pecuniary interest therein."}],"balance_after":3809000,"source":{"system":"sec-edgar","filing":"0001654954-20-002076","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420002076/section16.xml","form_type":"4"}},{"id":3309173,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"Common Stock","published_at":"2020-01-16T12:07:45.000Z","date":"2020-01-14","kind":"purchase","acquired":true,"shares":125000,"price":1,"value":125000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The number of shares acquired by Mr. Coffman as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Coffman after giving effect to this acquisition includes (i) 125,000 shares held by him directly, (ii) 3,684,000 shares held by Edge of Business, LLC (\"Edge\"), and (iii) 8,750,000 shares held by CBD Holding, LLC (\"CBDH\"), of which unrestricted voting rights to 2,187,500 shares vested on December 20, 2019.   The unrestricted voting rights to the remaining 6,562,500 shares of common stock held by CBDH vest as follows: (i) 2,187,500 shares will vest on December 20, 2020; (ii) an additional 2,187,500 shares will vest on June 30, 2022; and (iii) the remaining 2,187,500 shares will vest on December 20, 2023.  The independent chairman of the Audit Committee of the Issuer's Board of Directors holds voting rights over the remaining 6,562,500 shares for which unrestricted voting rights have yet to vest under the terms of a Voting Proxy Agreement dated December 20, 2018 (the \"Proxy Agreement\"), and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors.   Mr. R. Scott Coffman holds voting and dispositive control over securities held of record by Edge.  Mr. Coffman disclaims beneficial ownership of the securities held of record by Edge except to the extent of his pecuniary interest therein.  Mr. Coffman holds voting and dispositive control over securities held of record by CBDH except to the extent limited by the Proxy Agreement.  Mr. Coffman disclaims beneficial ownership of the securities held of record by CBDH except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The number of shares acquired by Mr. Coffman as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Coffman after giving effect to this acquisition includes (i) 125,000 shares held by him directly, (ii) 3,684,000 shares held by Edge of Business, LLC (\"Edge\"), and (iii) 8,750,000 shares held by CBD Holding, LLC (\"CBDH\"), of which unrestricted voting rights to 2,187,500 shares vested on December 20, 2019.   The unrestricted voting rights to the remaining 6,562,500 shares of common stock held by CBDH vest as follows: (i) 2,187,500 shares will vest on December 20, 2020; (ii) an additional 2,187,500 shares will vest on June 30, 2022; and (iii) the remaining 2,187,500 shares will vest on December 20, 2023.  The independent chairman of the Audit Committee of the Issuer's Board of Directors holds voting rights over the remaining 6,562,500 shares for which unrestricted voting rights have yet to vest under the terms of a Voting Proxy Agreement dated December 20, 2018 (the \"Proxy Agreement\"), and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors.   Mr. R. Scott Coffman holds voting and dispositive control over securities held of record by Edge.  Mr. Coffman disclaims beneficial ownership of the securities held of record by Edge except to the extent of his pecuniary interest therein.  Mr. Coffman holds voting and dispositive control over securities held of record by CBDH except to the extent limited by the Proxy Agreement.  Mr. Coffman disclaims beneficial ownership of the securities held of record by CBDH except to the extent of his pecuniary interest therein."}],"balance_after":12559000,"source":{"system":"sec-edgar","filing":"0001654954-20-000514","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420000514/section16.xml","form_type":"4"}},{"id":3343352,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"stock option","published_at":"2019-12-12T21:34:03.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":46666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46666,"derivative":{"exercise_price":3.15,"exercise_date":"2022-01-01","expiration_date":"2024-12-11","underlying":"common stock","underlying_shares":46666},"source":{"system":"sec-edgar","filing":"0001654954-19-013873","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495419013873/section16.xml","form_type":"4"}},{"id":3343351,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"stock option","published_at":"2019-12-12T21:34:03.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":46667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46667,"derivative":{"exercise_price":3.15,"exercise_date":"2021-01-01","expiration_date":"2024-12-11","underlying":"common stock","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0001654954-19-013873","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495419013873/section16.xml","form_type":"4"}},{"id":3343350,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CO-CEO"}}],"security":"stock option","published_at":"2019-12-12T21:34:03.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":46667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46667,"derivative":{"exercise_price":3.15,"exercise_date":"2020-01-01","expiration_date":"2024-12-11","underlying":"common stock","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0001654954-19-013873","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495419013873/section16.xml","form_type":"4"}},{"id":3551329,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true}}],"security":"common stock","published_at":"2019-04-22T19:03:19.000Z","date":"2019-04-22","kind":"exercise","acquired":true,"shares":8750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares acquired represents shares issued to CBD Holding, LLC (\"CBDH\") under contract rights previously received on December 20, 2018 in connection with the closing of an Agreement and Plan of Merger dated December 3, 2018 following Shareholder Approval as disclosed in the Form 3 filed by the Reporting Person on December 28, 2018.   The unrestricted voting rights to these shares vests follows: (i) 2,187,500 shares will vest on December 20, 2019; (ii) an additional 2,187,500 shares will vest on December 20, 2020; (iii) an additional 2,187,500 shares will vest on June 30, 2022; and (iv) the remaining 2,187,500 shares will vest on December 20, 2023.  The independent chairman of the Audit Committee of the Issuer's Board of Directors holds voting rights over these shares under the terms of a Voting Proxy Agreement dated December 20, 2018 (the \"Proxy Agreement\") until they vest, and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors.  Mr. R. Scott Coffman holds voting and dispositive control over securities held of record by CBDH except to the extent limited by the Proxy Agreement.  Mr. Coffman disclaims beneficial ownership of the securities held of record by CBDH except to the extent of his pecuniary interest therein."}],"balance_after":12434000,"source":{"system":"sec-edgar","filing":"0001654954-19-004631","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495419004631/section16.xml","form_type":"4"}},{"id":3551328,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":95073,"kind":"person","name":"Coffman Raymond Scott","position":1,"cik":"0001761772","reported_name":"Coffman Raymond Scott","relationship":{"director":true}}],"security":"common stock","published_at":"2019-04-22T19:03:19.000Z","date":"2019-04-22","kind":"exercise","acquired":true,"shares":3684000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The number of shares acquired represents shares issued to Edge of Business, LLC (\"Edge\") under contract rights previously received on December 20, 2018 in connection with the closing of an Agreement and Plan of Merger dated December 3, 2018 following the approval by the Issuer's shareholders for the possible issuance of in excess of 19.99% of its presently outstanding common stock in accordance with the rules of the NYSE American, LLC (the \"Shareholder Approval\") as disclosed in the Form 3 filed by the Reporting Person on December 28, 2018.  Mr. R. Scott Coffman holds voting and dispositive control over securities held of record by Edge.  Mr. Coffman disclaims beneficial ownership of the securities held of record by Edge except to the extent of his pecuniary interest therein."}],"balance_after":3684000,"source":{"system":"sec-edgar","filing":"0001654954-19-004631","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495419004631/section16.xml","form_type":"4"}}]}